Marksans Pharma Limited Share Price Results

Stocks

Marksans Pharma Limited Share Price

Results

Quarterly results

Show figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR

Revenue

₹ 708.46+26.51% from last year

Operating profits

₹ 142.27+12.76% from last year

Net income

₹ 90.73+16.85% from last year

Financial reports

Data is unavailable

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2014	FY 2012
Net worth	2466.91	2065.05	1745.16	1202.27	886.50	636.01	542.48	470.86	433.43	454.32	142.18	-168.07
Fixed assets	981.96	775.94	486.31	428.31	309.36	302.72	269.73	279.38	266.98	269.65	145.65	165.35
Debt	23.09	29.09	41.59	41.29	18.74	18.89	100.22	117.96	109.71	87.90	159.74	178.80

View detailed balance sheet

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Operating	206.66	230.41	237.41	99.26	178.59	233.33	27.40	50.09	14.06	30.80	154.51	64.84
Investing	-49.01	-140.84	-259.21	-84.39	-44.85	-59.58	-13.48	-38.81	-20.73	-123.01	-33.19	-4.49
Financing	-65.15	-68.73	197.83	79.51	-15.29	-113.55	-20.78	3.38	-3.47	-57.75	16.99	-29.28

Financial ratios

Profitability ratios info2

ROA12.93%

ROE16.89%

ROCE22.5%

EPS8.4%

Net profit margin14.59%

Operating profit margin21.81%

Dividend per share0.8%

Operational ratios info2

Quick ratio2.85%

Current ratio4.62%

Interest coverage44.22%

Assets turnover0.93%

Debt to equity0.01%

Valuation ratios info2

P/E ratio27.6%

P/B ratio4.26%

Dividend yield0.35%

EV/EBITDA

Marksans Pharma is an Indian pharmaceutical company having a global footprint. Their strengths lie in research manufacturing and marketing of finished dosage pharmaceutical formulations. The company’s R&D capabilities include dossier development chemical synthesis process optimization formulation development analytical development and conducting stability studies. Its key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology Gastroenterology Antidiabetic Antibiotics Cardiovascular Pain Management Gynaecology among others. The company manufacture a wide range of solid oral dosage in the form of Tablets (plain enteric coated and film coated) Hard Gelatin Capsule and Soft Gelatin Capsules.

Grow your wealth with more research recommendations

+91

To visit the old Ventura website, click here.

Ventura Wealth Clients Login here

Quarterly results

Quarterly results

Financial reports

Financial ratios

Grow your wealth with more research recommendations

Corporate Address